Dr Agarwals Healthcare IPO Day 2: Subscription status, GMP, allotment and key details of the issue

Dr Agarwals Healthcare, a company engaged in the business of eye care, opened its subscription window on January 29 and is set close on January 31, with an IPO price band set between Rs 382 to Rs 402 per share. Let’s take a look at the subscription status of this mainboard issue so far on Day 2, GMP and other key details.

Dr Agarwals Healthcare IPO: Subscription status

Dr Agarwals Healthcare IPO, which opened for bidding on January 29, has seen 0.39 times overall subscription as of 2:33 PM on Day 2. The QIB category has led the demand with 0.95 times subscription, while the NII segment lags at 0.10 times. The retail portion stands at 0.21 times, while the employee and reservation categories have seen 0.16 times and 0.23 times subscription, respectively so far .

Dr Agarwals Healthcare IPO: GMP

The GMP for Dr Agarwals Healthcare IPO stands at Rs 3 on Day 2, suggesting a listing price of Rs 405 per share. This indicates to a 0.75% premium over the upper price band of Rs 402, in the unlisted market.

Dr Agarwals Healthcare IPO: Key highlights

The public issue aims to raise Rs 3,027.26 crore, comprising a fresh issue of Rs 300 crore and an OFS of Rs 2,727.26 crore, where existing shareholders are divesting 6.78 crore shares.

After the bidding process, the allotment is expected on February 3, and a tentative listing on February 5, on the BSE and NSE.

 » Read More

Related Articles

Rupee fall hurts India Inc hard

The rupee inched closer to the 88-mark against the US dollar on Monday, putting companies in import-sensitive sectors on the edge. While firms fear a surge in imported inflation on account of rupee depreciation, consumer electronics companies, for instance, are taking price hikes to protect margins. In sectors such as thermal power, where the cost

Bata India Q3 profit grows marginally to Rs 58.6 crore on weak demand

Footwear major Bata India on Monday reported a marginal 1% growth in its net profit at Rs 58.6 crore during the October-December quarter, as compared to Rs 57.9 crore in the same quarter in 2023-24. Bloomberg consensus estimates had pegged the net profit during the quarter at Rs 72 crore.  The company’s revenue from operations

NFRA must separate audit review and disciplinary roles: Experts

Even the National Financial Reporting Authority (NFRA) weighs its options after the Delhi High Court’s order quashing the show-cause notices issued by the regulator against the IL&FS and DHFL auditors, legal experts argue that the regulator would need to create separate divisions for the twin functions of audit review and disciplinary action to comply with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Rupee fall hurts India Inc hard

The rupee inched closer to the 88-mark against the US dollar on Monday, putting companies in import-sensitive sectors on the edge. While firms fear a surge in imported inflation on account of rupee depreciation, consumer electronics companies, for instance, are taking price hikes to protect margins. In sectors such as thermal power, where the cost

Bata India Q3 profit grows marginally to Rs 58.6 crore on weak demand

Footwear major Bata India on Monday reported a marginal 1% growth in its net profit at Rs 58.6 crore during the October-December quarter, as compared to Rs 57.9 crore in the same quarter in 2023-24. Bloomberg consensus estimates had pegged the net profit during the quarter at Rs 72 crore.  The company’s revenue from operations

NFRA must separate audit review and disciplinary roles: Experts

Even the National Financial Reporting Authority (NFRA) weighs its options after the Delhi High Court’s order quashing the show-cause notices issued by the regulator against the IL&FS and DHFL auditors, legal experts argue that the regulator would need to create separate divisions for the twin functions of audit review and disciplinary action to comply with

Reliance makes sports drinks foray with Spinner

Reliance Consumer Products on Monday entered the sports hydration drink segment with Spinner. The drink, which is being offered at Rs 10 for a 150 ml bottle, has been co-created with former Sri Lankan cricketer Muttiah Muralitharan. Reliance has disrupted the beverages market with aggressive pricing of Campa Cola, which it relaunched in 2023.  ALSO

Supertails banks on services to counter q-comm disruption in pet care

Bengaluru-based pet care startup Supertails is betting big on services like veterinary care and grooming to set itself apart from quick commerce majors like Zepto, Blinkit, and Instamart, which are aggressively expanding their pet supply offerings. Backed by Fireside Ventures, the startup plans to launch offline centres in select cities that will function as both